The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Therapeutic Pipeline Program, 2018Dual Leucine Zipper Kinase Inhibitors for Parkinson's Disease
Study Rationale:
There are no therapies that slow down the loss of brain cells affected by Parkinson's disease. Prior research suggests that dual leucine zipper kinase (DLK) regulates stress response... -
Research Grant, 2018Peripheral Inflammatory Cytokine Profiling in Parkinson's Disease
Study Rationale:
A growing body of research suggests that inflammation contributes to Parkinson's disease. However, the stages in the disease process that inflammation is prevalent and important are... -
Research Grant, 2018Conformational Changes in the Activation of the Ubiquitin Ligase Parkin
Study Rationale:
Parkin is an enzyme that modifies proteins on mitochondria in response to damage. In previous MJFF-funded research, we examined how Parkin changes its conformation as it goes from an... -
Mitochondrial Biomarkers Program, 2018Novel Mitochondrial Biomarkers in Genetically Stratified Parkinson's Disease Patients
Study Rationale:
Parkinson's disease has many causes and can be thought of as an umbrella term for patients with a diverse set of experiences. Research suggest that dysfunction of mitochondria (e.g... -
Mitochondrial Biomarkers Program, 2018Mitofusin Ubiquitination as a Biomarker to Stratify Parkinson's Disease Patients
Study Rationale:
Some forms of early-onset Parkinson's disease are caused by dysfunction in the recycling of mitochondria, which are the powerhouses of our cells. Damaged mitochondria that need to be... -
Research Grant, 2018Data Driven Subtyping of Parkinson's Disease Patients in the BioFIND Study
Study Rationale:
Parkinson's disease is highly variable, so each patient has a unique experience of the disease and diverse contributing factors. To understand and ultimately treat Parkinson's, we...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.